Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses

BACKGROUND: SARS-CoV-2 variants of concern (VOCs) have threatened COVID-19 vaccine effectiveness. We aimed to assess the effectiveness of the ChAdOx1 nCoV-19 vaccine, predominantly against the delta (B.1.617.2) variant, in addition to the cellular immune response to vaccination. METHODS: We did a te...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiruvengadam, Ramachandran, Awasthi, Amit, Medigeshi, Guruprasad, Bhattacharya, Sankar, Mani, Shailendra, Sivasubbu, Sridhar, Shrivastava, Tripti, Samal, Sweety, Rathna Murugesan, Deepika, Koundinya Desiraju, Bapu, Kshetrapal, Pallavi, Pandey, Rajesh, Scaria, Vinod, Kumar Malik, Praveen, Taneja, Juhi, Binayke, Akshay, Vohra, Tarini, Zaheer, Aymaan, Rathore, Deepak, Ahmad Khan, Naseem, Shaman, Heena, Ahmed, Shubbir, Kumar, Rajesh, Deshpande, Suprit, Subramani, Chandru, Wadhwa, Nitya, Gupta, Nimesh, Pandey, Anil K, Bhattacharya, Jayanta, Agrawal, Anurag, Vrati, Sudhanshu, Bhatnagar, Shinjini, Garg, Pramod Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616567/
https://www.ncbi.nlm.nih.gov/pubmed/34838183
http://dx.doi.org/10.1016/S1473-3099(21)00680-0

Ejemplares similares

Ejemplares similares